316
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effect on Patients’ Visual Acuity and Grade, Secondary to Non-Attendance at Treatment Centers, Post Referral from Diabetic RetinaScreen Ireland

, , , , , & ORCID Icon show all
Pages 183-190 | Received 16 Sep 2022, Accepted 30 Dec 2022, Published online: 11 Jan 2023

References

  • Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
  • Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
  • Tracey M, Racine E, Riordan F, et al. Understanding the uptake of a national retinopathy screening programme: an audit of people with diabetes in two large primary care centres. HRB Open Res. 2019;2:17. doi:10.12688/hrbopenres.12926.3
  • Pandey R, Morgan MM, Murphy C, et al. Irish national diabetic RetinaScreen programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1). Br J Ophthalmol. 2022;106:409–414. doi:10.1136/bjophthalmol-2020-317508
  • Kelly SR, Loiselle AR, Pandey R, et al. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2). Acta Diabetol. 2021;58(5):643–650. doi:10.1007/s00592-021-01671-4
  • Zoega GM, Gunnarsdóttir P, Björnsdóttir S, et al. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand. 2005;83(6):687–690. doi:10.1111/j.1600-0420.2005.00541.x
  • James M, Turner DA, Broadbent DM, et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J. 2000;320:1627–1631. doi:10.1136/bmj.320.7250.1627
  • Scanlon PH. The English national screening programme for diabetic retinopathy 2003–2016. Acta Diabetol. 2017;54(6):515–525. doi:10.1007/s00592-017-0974-1
  • Broadbent DM, Wang A, Cheyne CP, et al. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia. 2021;64(1):56–69. doi:10.1007/s00125-020-05313-2
  • Covid-19 HSE Clinical Guidance and Evidence. HSE interim clinical guidance on management of diabetes during the COVID-19 pandemic 118. HLI at Health Library Ireland @ HSE.
  • Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol. 1999;128(3):324–330. doi:10.1016/s0002-9394(99)00146-4
  • Wolff DL, Waldorff FB, Von Plessen C, et al. Rate and predictors for non-attendance of patients undergoing hospital outpatient treatment for chronic diseases: a register-based cohort study. BMC Health Serv Res. 2019;19(1):1–11. doi:10.1186/s12913-019-4208-9
  • Philpott-Morgan S, Thakrar DB, Symons J, et al. Characterising the nationwide burden and predictors of unkept outpatient appointments in the national health service in England: a cohort study using a machine learning approach. PLOS Med. 2021;18(10):e1003783. doi:10.1371/journal.pmed.1003783
  • Greenan E, Salim M, Coakley DN, James M. The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre. Ir J Med Sci. 2019;188(4):1207–1212. doi:10.1007/s11845-019-02009-4
  • Faes L, Fu DJ, Huemer J, et al. A virtual-clinic pathway for patients referred from a national diabetes eye screening programme reduces service demands whilst maintaining quality of care. Eye. 2021;35(8):2260–2269. doi:10.1038/s41433-020-01240-z
  • Keenum Z, McGwin G, Witherspoon CD, et al. Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 2016;134(11):1221–1228. doi:10.1001/jamaophthalmol.2016.3081
  • Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the diabetic retinopathy awareness program. Ophthalmology. 2001;108(3):563–571. doi:10.1016/S0161-6420(00)00600-X
  • Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med. 1998;15(Suppl 3):S14–24.
  • Forster AS, Forbes A, Dodhia H, et al. Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study. Diabetologia. 2013;56(10):2187–2193. doi:10.1007/s00125-013-2975-0
  • Strutton R, Du Chemin A, Stratton IM, Forster AS. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open. 2016;6:1–6. doi:10.1136/bmjopen-2015-010952
  • Murphy R, Taaffe C, Unit P, Division A. Patients’ reasons for non-attendance at outpatient appointments: a literature synthesis table of contents; 2019.
  • Carreras-García D, Delgado-Gómez D, Baca-García E, Artés-Rodriguez A. A probabilistic patient scheduling model with time variable slots. Comput Math Methods Med. 2020;2020:9727096. doi:10.1155/2020/9727096
  • Halbert RJ, Leung KM, Nichol JM, Legorreta AP. Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial. Diabetes Care. 1999;22:752–755. doi:10.2337/diacare.22.5.752
  • Dervan E, Lillis D, Flynn L, et al. Factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci. 2008;177(4):303–308. doi:10.1007/s11845-008-0192-5
  • Moinul P, Barbosa J, Qian J, et al. Does patient education improve compliance to routine diabetic retinopathy screening? J Telemed Telecare. 2020;26:161–173. doi:10.1177/1357633X18804749